Skip to Content

AcuCort AB - Stock Quote ACUC

Rating as of

Morningstar's AcuCort AB Stock Analysis

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

AcuCort AB's Company Profile

Business Description

AcuCort AB develops and commercializes Dexa ODF, a fast-blown film to put on the tongue, primarily for the treatment of acute allergic reactions, chills in children and chemotherapy-induced nausea and vomiting.

Kullagatan 8
Helsingborg, 252 20, Sweden
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2019
Stock Type
Employees 1